Cargando…
Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors
Müllerian inhibiting substance (MIS), also called anti-Müllerian hormone (AMH), is a member of the transforming growth factor-β super-family of growth and differentiation response modifiers. It is produced in immature Sertoli cells in male embryos and binds to MIS/AMH receptors in primordial Mülleri...
Autores principales: | Kim, Jang Heub, MacLaughlin, David T., Donahoe, Patricia K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175594/ https://www.ncbi.nlm.nih.gov/pubmed/25264524 http://dx.doi.org/10.5468/ogs.2014.57.5.343 |
Ejemplares similares
-
Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone
por: Ferguson, Jackie MC, et al.
Publicado: (2018) -
Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis
por: Chung, Youn Jee, et al.
Publicado: (2015) -
The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor in myoma and adenomyosis
por: Kim, Shin Young, et al.
Publicado: (2018) -
Inhibin B and anti-Müllerian hormone/Müllerian-inhibiting substance may contribute to the male bias in autism
por: Pankhurst, M W, et al.
Publicado: (2012) -
Functional profiles of Müllerian inhibiting substance/anti-Müllerian hormone (MIS/AMH) in primarily cultured endometrial cancer cells
por: Kim, Sang Il, et al.
Publicado: (2021)